Uncategorized
BLOG: The best thing I saw at AAO? Allergan’s social contract
The AAO meeting is always a great time to catch up with friends and learn about new technologies. To be sure, this meeting had some exciting new approvals, like Shire’s Xiidra for dry eye, Alcon’s CyPass micro-stent for glaucoma, and the AMO Symfony implant—the first extended depth-of-focus implant in the U.S. While technology is great, I was most impressed with Allergan's announcement by CEO Brent Saunders of the company's new social contract.